Key result
Three distinct antigenic sites (site 1, site 2, and site 3) recognized by neutralizing monoclonal antibodies were identified across Sabin vaccine strains of poliovirus serotypes 1, 2, and 3.
Population
Sabin vaccine strains of poliovirus of serotypes 1, 2 and 3
Design
Preclinical
Authors
Loading...
No immediate change to polio vaccination; leaves open translation of antigenic sites to human vaccine design.
The study maps three distinct antigenic sites on poliovirus serotypes 1, 2, and 3, providing structural insights into viral neutralization.
Minor et al. (1986) studied Poliovirus. Monoclonal antibodies was evaluated on Identification of antigenic sites. Three distinct antigenic sites (site 1, site 2, and site 3) recognized by neutralizing monoclonal antibodies were identified across Sabin vaccine strains of poliovirus serotypes 1, 2, and 3.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: